{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By KEVIN ALLISON", "person": [{"rank": 1, "role": "reported", "firstname": "Kevin", "organization": "", "lastname": "ALLISON"}]}, "abstract": null, "type_of_material": "News", "word_count": "401", "lead_paragraph": "The strategic rationale of the merger makes sense, but the estimated $30 billion of value creation from cost savings is too generous.", "pub_date": "2015-12-12T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Dow and DuPont Test the Limits of Deal-Making", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "The strategic rationale of the merger makes sense, but the estimated $30 billion of value creation from cost savings is too generous.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/12/12/business/dealbook/dow-and-dupont-test-the-limits-of-deal-making.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Dow Chemical Company", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "DuPont Co", "name": "organizations"}], "blog": [], "_id": "566afae438f0d857ec8b0c0a", "source": "The New York Times"}